CL
Colgate-Palmolive Company
Price Chart
Latest Quote
$88.17
+3.07 (+3.61%)
Current Price
| Previous Close | $85.10 |
| Open | $85.97 |
| Day High | $88.24 |
| Day Low | $85.78 |
| Volume | 1,381,076 |
Stock Information
| Quarterly Dividend / Yield | $2.12 / 2.49% |
| Shares Outstanding | 800.19M |
| Quarterly Dividend Yield | 2.49% |
| Quarterly Dividend | $2.12 |
| Total Debt | $7.97B |
| Cash Equivalents | $1.42B |
| Revenue | $20.80B |
| Net Income | $2.09B |
| Sector | Consumer Defensive |
| Industry | Household & Personal Products |
| Market Cap | $70.88B |
| P/E Ratio | 34.33 |
| EPS (TTM) | $2.58 |
| Exchange | NYQ |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $74.99B |
| Sales | $20.80B |
| Income | $2.09B |
| Book/sh | $0.18 |
| Cash/sh | $1.77 |
| Employees | 34K |
Financial Ratios
| Quick Ratio | 0.56 |
| Current Ratio | 1.02 |
| Debt/Eq | 1640.54 |
| EPS Growth TTM | -6.40% |
Returns & Margins
| ROA | 16.10% |
| ROE | 363.58% |
| Gross Margin | 60.06% |
| Operating Margin | 20.92% |
| Profit Margin | 10.04% |
Ownership
| Insider Ownership | 0.15% |
| Institutional Ownership | 88.12% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 21.92 |
| PEG | 1.58 |
| P/S | 3.41 |
| P/B | 489.39 |
Analyst Data
| Recommendation | buy |
| Target Price | $95.84 |
Technical Indicators
| SMA20 | $88.80 |
| SMA50 | $86.25 |
| SMA200 | $83.40 |
| RSI | 51.45 |
| ATR | 2.2921 |
| Shares Float | 750.80M |
| Short Float | 2.77% |
| Short Ratio | 3.72 |
| Volatility | 0.32 |
| Rel Volume | 1.13 |
Performance History
| Week | -1.72% |
| Month | +0.48% |
| Quarter | -4.73% |
| 6 Months | +14.68% |
| YTD | +15.43% |
| Year | +0.69% |
| 3 Years | +27.84% |
| 5 Years | +19.07% |
| 10 Years | +56.05% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-05 | $88.58 | 5,961,383 |
| 2026-06-04 | $85.10 | 5,636,300 |
| 2026-06-03 | $84.87 | 7,489,400 |
| 2026-06-02 | $88.27 | 4,153,300 |
| 2026-06-01 | $88.43 | 6,343,900 |
| 2026-05-29 | $90.13 | 6,671,500 |
| 2026-05-28 | $91.66 | 3,790,300 |
| 2026-05-27 | $91.29 | 3,768,500 |
| 2026-05-26 | $89.85 | 5,811,800 |
| 2026-05-22 | $90.61 | 3,771,900 |
| 2026-05-21 | $90.44 | 4,645,500 |
| 2026-05-20 | $90.35 | 7,058,000 |
| 2026-05-19 | $90.02 | 5,664,400 |
| 2026-05-18 | $89.92 | 4,650,000 |
| 2026-05-15 | $88.13 | 4,862,400 |
| 2026-05-14 | $88.84 | 5,607,800 |
| 2026-05-13 | $87.87 | 5,590,700 |
| 2026-05-12 | $87.44 | 4,995,100 |
| 2026-05-11 | $86.74 | 4,398,400 |
| 2026-05-08 | $87.55 | 4,435,400 |
| 2026-05-07 | $87.36 | 5,012,800 |
| 2026-05-06 | $88.16 | 5,768,000 |
About Colgate-Palmolive Company
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under the Colgate, Palmolive, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, EltaMD, Filorga, Irish Spring, Lady Speed Stick, PCA SKIN, Protex, Sanex, Softsoap, Speed Stick, Ajax, Axion, Fabuloso, Murphy, Soupline, and Suavitel brands to a range of traditional and eCommerce retailers, wholesalers, and distributors, as well as dentists and skin health professionals. It also offers pharmaceutical products for dentists and other oral health professionals. The Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill's Science Diet brand; and a range of therapeutic pet products to help nutritionally support dogs and cats in different stages of health under the Hill's Prescription Diet brand; and a fresh pet food sold to pet specialty and other retailers in Australia under Prime100 brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.
đ° Latest News
OPEC crude output drops to lowest level in 37 years
Investing.com âĸ 2026-06-05T14:59:03ZEquity returns likely to moderate, but dips remain buying opportunities: GS
Investing.com âĸ 2026-06-04T15:32:06ZA Look At Colgate Palmolive (CL) Valuation After Mixed Recent Share Price Performance
Simply Wall St. âĸ 2026-06-03T21:18:12Z
EU proposes naval mission to clear Hormuz mines
Investing.com âĸ 2026-06-03T13:50:56ZIran nuclear risk higher than before U.S.-Israel strikes, UN says
Investing.com âĸ 2026-06-03T13:42:59ZIs Colgate-Palmolive Stock Underperforming the Dow?
Barchart âĸ 2026-06-03T13:20:54Z
EU weighs freezing Russian oil price cap as Middle East war lifts crude prices
Investing.com âĸ 2026-05-31T10:28:49ZUkrainian drones hit Russian port, tanker, and oil depot, officials say
Investing.com âĸ 2026-05-30T08:33:39Z2 Weeks in May Rekindled My Love for Stock Picking. Hereâs My Daily Trading Routine.
Barchart âĸ 2026-05-29T19:20:13Z
2 Large-Cap Stocks to Target This Week and 1 We Ignore
StockStory âĸ 2026-05-29T16:00:38Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $7,579,000,000 | $7,410,000,000 | $7,636,000,000 | $7,254,000,000 |
| Cost Of Revenue | $8,131,000,000 | $7,940,000,000 | $8,131,000,000 | $7,719,000,000 |
| Total Revenue | $20,382,000,000 | $20,101,000,000 | $19,457,000,000 | $17,967,000,000 |
| Operating Revenue | $20,382,000,000 | $20,101,000,000 | $19,457,000,000 | $17,967,000,000 |
| Expenses | ||||
| Interest Expense | $267,000,000 | $292,000,000 | $287,000,000 | $167,000,000 |
| Total Expenses | $16,149,000,000 | $15,771,000,000 | $15,372,000,000 | $14,350,000,000 |
| Other Income Expense | $-982,000,000 | $-149,000,000 | $-461,000,000 | $-804,000,000 |
| Other Non Operating Income Expenses | $-73,000,000 | $-165,000,000 | $-442,000,000 | $-145,000,000 |
| Net Non Operating Interest Income Expense | $-192,000,000 | $-225,000,000 | $-232,000,000 | $-153,000,000 |
| Interest Expense Non Operating | $267,000,000 | $292,000,000 | $287,000,000 | $167,000,000 |
| Operating Expense | $8,018,000,000 | $7,831,000,000 | $7,241,000,000 | $6,631,000,000 |
| Other Operating Expenses | - | - | - | $65,000,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $2,132,000,000 | $2,889,000,000 | $2,300,000,000 | $1,785,000,000 |
| Net Interest Income | $-192,000,000 | $-225,000,000 | $-232,000,000 | $-153,000,000 |
| Interest Income | $75,000,000 | $67,000,000 | $55,000,000 | $14,000,000 |
| Normalized Income | $2,818,652,174 | $2,893,624,368 | $2,326,064,000 | $2,280,869,000 |
| Net Income From Continuing And Discontinued Operation | $2,132,000,000 | $2,889,000,000 | $2,300,000,000 | $1,785,000,000 |
| Total Operating Income As Reported | $3,306,000,000 | $4,268,000,000 | $3,984,000,000 | $2,893,000,000 |
| Net Income Common Stockholders | $2,132,000,000 | $2,889,000,000 | $2,300,000,000 | $1,785,000,000 |
| Net Income | $2,132,000,000 | $2,889,000,000 | $2,300,000,000 | $1,785,000,000 |
| Net Income Including Noncontrolling Interests | $2,261,000,000 | $3,049,000,000 | $2,455,000,000 | $1,967,000,000 |
| Net Income Continuous Operations | $2,261,000,000 | $3,049,000,000 | $2,455,000,000 | $1,967,000,000 |
| Pretax Income | $3,059,000,000 | $3,956,000,000 | $3,392,000,000 | $2,660,000,000 |
| Special Income Charges | $-928,000,000 | $0 | $-25,000,000 | $-693,000,000 |
| Earnings From Equity Interest | $20,000,000 | $22,000,000 | $17,000,000 | $12,000,000 |
| Interest Income Non Operating | $75,000,000 | $67,000,000 | $55,000,000 | $14,000,000 |
| Operating Income | $4,233,000,000 | $4,330,000,000 | $4,085,000,000 | $3,617,000,000 |
| Depreciation Amortization Depletion Income Statement | $78,000,000 | $75,000,000 | $72,000,000 | $80,000,000 |
| Depreciation And Amortization In Income Statement | $78,000,000 | $75,000,000 | $72,000,000 | $80,000,000 |
| Amortization Of Intangibles Income Statement | $78,000,000 | $75,000,000 | $72,000,000 | $80,000,000 |
| Gross Profit | $12,251,000,000 | $12,161,000,000 | $11,326,000,000 | $10,248,000,000 |
| Per Share | ||||
| Diluted EPS | $2.63 | $3.51 | $2.77 | $2.13 |
| Basic EPS | $2.64 | $3.53 | $2.78 | $2.13 |
| Other | ||||
| Tax Effect Of Unusual Items | $-242,347,826 | $-1,375,632 | $-9,936,000 | $-175,131,000 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $4,885,000,000 | $4,859,000,000 | $4,282,000,000 | $4,043,000,000 |
| Total Unusual Items | $-929,000,000 | $-6,000,000 | $-36,000,000 | $-671,000,000 |
| Total Unusual Items Excluding Goodwill | $-929,000,000 | $-6,000,000 | $-36,000,000 | $-671,000,000 |
| Reconciled Depreciation | $630,000,000 | $605,000,000 | $567,000,000 | $545,000,000 |
| EBITDA (Bullshit earnings) | $3,956,000,000 | $4,853,000,000 | $4,246,000,000 | $3,372,000,000 |
| EBIT | $3,326,000,000 | $4,248,000,000 | $3,679,000,000 | $2,827,000,000 |
| Diluted Average Shares | $811,100,000 | $823,200,000 | $829,200,000 | $838,800,000 |
| Basic Average Shares | $808,700,000 | $819,100,000 | $827,400,000 | $836,400,000 |
| Diluted NI Availto Com Stockholders | $2,132,000,000 | $2,889,000,000 | $2,300,000,000 | $1,785,000,000 |
| Minority Interests | $-129,000,000 | $-160,000,000 | $-155,000,000 | $-182,000,000 |
| Tax Provision | $798,000,000 | $907,000,000 | $937,000,000 | $693,000,000 |
| Impairment Of Capital Assets | $919,000,000 | $0 | $0 | $721,000,000 |
| Restructuring And Mergern Acquisition | $9,000,000 | $0 | $0 | $19,000,000 |
| Gain On Sale Of Security | $-1,000,000 | $-6,000,000 | $-11,000,000 | $22,000,000 |
| Other Taxes | $37,000,000 | $27,000,000 | $18,000,000 | $-14,000,000 |
| Amortization | $78,000,000 | $75,000,000 | $72,000,000 | $80,000,000 |
| Selling General And Administration | $7,903,000,000 | $7,729,000,000 | $7,151,000,000 | $6,565,000,000 |
| Gain On Sale Of Ppe | - | $0 | $0 | $47,000,000 |
| Other Special Charges | - | - | $25,000,000 | - |
| Write Off | - | - | - | - |
Fetched: 2026-05-25
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-4,604,000,000 | $-4,816,000,000 | $-4,688,000,000 | $-4,871,000,000 |
| Total Assets | $16,330,000,000 | $16,046,000,000 | $16,393,000,000 | $15,731,000,000 |
| Total Non Current Assets | $10,621,000,000 | $10,729,000,000 | $11,114,000,000 | $10,618,000,000 |
| Other Non Current Assets | $1,098,000,000 | $1,084,000,000 | $1,021,000,000 | $904,000,000 |
| Non Current Deferred Assets | $205,000,000 | $195,000,000 | $214,000,000 | $135,000,000 |
| Non Current Deferred Taxes Assets | $205,000,000 | $195,000,000 | $214,000,000 | $135,000,000 |
| Goodwill And Other Intangible Assets | $4,658,000,000 | $5,028,000,000 | $5,297,000,000 | $5,272,000,000 |
| Other Intangible Assets | $1,536,000,000 | $1,756,000,000 | $1,887,000,000 | $1,920,000,000 |
| Current Assets | $5,709,000,000 | $5,317,000,000 | $5,279,000,000 | $5,113,000,000 |
| Other Current Assets | $714,000,000 | $713,000,000 | $793,000,000 | $760,000,000 |
| Inventory | $2,032,000,000 | $1,987,000,000 | $1,934,000,000 | $2,074,000,000 |
| Receivables | $1,675,000,000 | $1,521,000,000 | $1,586,000,000 | $1,504,000,000 |
| Accounts Receivable | $1,675,000,000 | $1,521,000,000 | $1,586,000,000 | $1,504,000,000 |
| Allowance For Doubtful Accounts Receivable | $-90,000,000 | $-85,000,000 | $-80,000,000 | $-70,000,000 |
| Gross Accounts Receivable | $1,765,000,000 | $1,606,000,000 | $1,666,000,000 | $1,574,000,000 |
| Cash Cash Equivalents And Short Term Investments | $1,288,000,000 | $1,096,000,000 | $966,000,000 | $775,000,000 |
| Cash And Cash Equivalents | $1,288,000,000 | $1,096,000,000 | $966,000,000 | $775,000,000 |
| Debt | ||||
| Net Debt | $6,700,000,000 | $6,853,000,000 | $7,583,000,000 | $7,991,000,000 |
| Total Debt | $8,554,000,000 | $8,512,000,000 | $9,064,000,000 | $9,271,000,000 |
| Long Term Debt And Capital Lease Obligation | $7,319,000,000 | $7,745,000,000 | $8,639,000,000 | $9,138,000,000 |
| Long Term Debt | $6,871,000,000 | $7,289,000,000 | $8,219,000,000 | $8,741,000,000 |
| Current Debt And Capital Lease Obligation | $1,235,000,000 | $767,000,000 | $425,000,000 | $133,000,000 |
| Current Debt | $1,117,000,000 | $660,000,000 | $330,000,000 | $25,000,000 |
| Other Current Borrowings | $1,117,000,000 | $660,000,000 | $330,000,000 | $25,000,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $15,965,000,000 | $15,502,000,000 | $15,436,000,000 | $14,925,000,000 |
| Total Non Current Liabilities Net Minority Interest | $9,112,000,000 | $9,743,000,000 | $10,695,000,000 | $10,921,000,000 |
| Other Non Current Liabilities | $362,000,000 | $320,000,000 | $305,000,000 | $271,000,000 |
| Non Current Deferred Liabilities | $181,000,000 | $343,000,000 | $361,000,000 | $383,000,000 |
| Non Current Deferred Taxes Liabilities | $181,000,000 | $343,000,000 | $361,000,000 | $383,000,000 |
| Current Liabilities | $6,853,000,000 | $5,759,000,000 | $4,741,000,000 | $4,004,000,000 |
| Other Current Liabilities | $22,000,000 | $23,000,000 | $26,000,000 | $15,000,000 |
| Payables And Accrued Expenses | $5,500,000,000 | $4,876,000,000 | $4,194,000,000 | $3,774,000,000 |
| Interest Payable | $72,000,000 | $72,000,000 | $78,000,000 | $59,000,000 |
| Payables | $3,144,000,000 | $2,778,000,000 | $2,201,000,000 | $2,001,000,000 |
| Dividends Payable | $418,000,000 | $408,000,000 | $0 | - |
| Total Tax Payable | $637,000,000 | $565,000,000 | $503,000,000 | $450,000,000 |
| Income Tax Payable | $383,000,000 | $403,000,000 | $336,000,000 | $317,000,000 |
| Accounts Payable | $2,089,000,000 | $1,805,000,000 | $1,698,000,000 | $1,551,000,000 |
| Equity | ||||
| Common Stock Equity | $54,000,000 | $212,000,000 | $609,000,000 | $401,000,000 |
| Total Equity Gross Minority Interest | $365,000,000 | $544,000,000 | $957,000,000 | $806,000,000 |
| Stockholders Equity | $54,000,000 | $212,000,000 | $609,000,000 | $401,000,000 |
| Gains Losses Not Affecting Retained Earnings | $-3,879,000,000 | $-4,222,000,000 | $-3,937,000,000 | $-4,055,000,000 |
| Other Equity Adjustments | $-3,879,000,000 | $-4,222,000,000 | $-3,937,000,000 | $-4,055,000,000 |
| Retained Earnings | $26,595,000,000 | $26,145,000,000 | $25,289,000,000 | $24,573,000,000 |
| Other Equity Interest | - | - | - | $-1,000,000 |
| Other | ||||
| Treasury Shares Number | $664,466,836 | $653,131,662 | $644,293,591 | $635,493,754 |
| Ordinary Shares Number | $801,239,524 | $812,574,698 | $821,412,769 | $830,212,606 |
| Share Issued | $1,465,706,360 | $1,465,706,360 | $1,465,706,360 | $1,465,706,360 |
| Tangible Book Value | $-4,604,000,000 | $-4,816,000,000 | $-4,688,000,000 | $-4,871,000,000 |
| Invested Capital | $8,042,000,000 | $8,161,000,000 | $9,158,000,000 | $9,167,000,000 |
| Working Capital | $-1,144,000,000 | $-442,000,000 | $538,000,000 | $1,109,000,000 |
| Capital Lease Obligations | $566,000,000 | $563,000,000 | $515,000,000 | $505,000,000 |
| Total Capitalization | $6,925,000,000 | $7,501,000,000 | $8,828,000,000 | $9,142,000,000 |
| Minority Interest | $311,000,000 | $332,000,000 | $348,000,000 | $405,000,000 |
| Treasury Stock | $28,450,000,000 | $27,358,000,000 | $26,017,000,000 | $25,128,000,000 |
| Additional Paid In Capital | $4,322,000,000 | $4,181,000,000 | $3,808,000,000 | $3,546,000,000 |
| Capital Stock | $1,466,000,000 | $1,466,000,000 | $1,466,000,000 | $1,466,000,000 |
| Common Stock | $1,466,000,000 | $1,466,000,000 | $1,466,000,000 | $1,466,000,000 |
| Employee Benefits | $1,241,000,000 | $1,306,000,000 | $1,390,000,000 | $1,129,000,000 |
| Non Current Pension And Other Postretirement Benefit Plans | $1,241,000,000 | $1,306,000,000 | $1,390,000,000 | $1,129,000,000 |
| Non Current Accrued Expenses | $9,000,000 | $29,000,000 | $0 | $0 |
| Long Term Capital Lease Obligation | $448,000,000 | $456,000,000 | $420,000,000 | $397,000,000 |
| Current Capital Lease Obligation | $118,000,000 | $107,000,000 | $95,000,000 | $108,000,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $96,000,000 | $93,000,000 | $96,000,000 | $82,000,000 |
| Current Accrued Expenses | $2,356,000,000 | $2,098,000,000 | $1,993,000,000 | $1,773,000,000 |
| Goodwill | $3,122,000,000 | $3,272,000,000 | $3,410,000,000 | $3,352,000,000 |
| Net PPE | $4,660,000,000 | $4,422,000,000 | $4,582,000,000 | $4,307,000,000 |
| Accumulated Depreciation | $-6,196,000,000 | $-5,705,000,000 | $-5,704,000,000 | $-5,276,000,000 |
| Gross PPE | $10,856,000,000 | $10,127,000,000 | $10,286,000,000 | $9,583,000,000 |
| Other Properties | $1,516,000,000 | $1,580,000,000 | $1,647,000,000 | $1,577,000,000 |
| Machinery Furniture Equipment | $6,935,000,000 | $6,265,000,000 | $6,365,000,000 | $6,001,000,000 |
| Buildings And Improvements | $2,171,000,000 | $2,056,000,000 | $2,047,000,000 | $1,825,000,000 |
| Land And Improvements | $234,000,000 | $226,000,000 | $227,000,000 | $180,000,000 |
| Properties | $0 | $0 | $0 | $0 |
| Inventories Adjustments Allowances | $-125,000,000 | $-121,000,000 | $-129,000,000 | $-148,000,000 |
| Finished Goods | $1,479,000,000 | $1,431,000,000 | $1,411,000,000 | $1,508,000,000 |
| Work In Process | $46,000,000 | $46,000,000 | $46,000,000 | $48,000,000 |
| Raw Materials | $632,000,000 | $631,000,000 | $606,000,000 | $666,000,000 |
Fetched: 2026-05-25
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $3,634,000,000 | $3,546,000,000 | $3,040,000,000 | $1,860,000,000 |
| Operating Activities | ||||
| Operating Cash Flow | $4,198,000,000 | $4,107,000,000 | $3,745,000,000 | $2,556,000,000 |
| Cash Flow From Continuing Operating Activities | $4,198,000,000 | $4,107,000,000 | $3,745,000,000 | $2,556,000,000 |
| Operating Gains Losses | - | - | - | $-47,000,000 |
| Investing Activities | ||||
| Capital Expenditure | $-564,000,000 | $-561,000,000 | $-705,000,000 | $-696,000,000 |
| Investing Cash Flow | $-817,000,000 | $-534,000,000 | $-742,000,000 | $-1,601,000,000 |
| Cash Flow From Continuing Investing Activities | $-817,000,000 | $-534,000,000 | $-742,000,000 | $-1,601,000,000 |
| Net Other Investing Changes | $-14,000,000 | $37,000,000 | $-33,000,000 | $5,000,000 |
| Capital Expenditure Reported | $-564,000,000 | $-561,000,000 | $-705,000,000 | $-696,000,000 |
| Financing Activities | ||||
| Repurchase Of Capital Stock | $-1,210,000,000 | $-1,739,000,000 | $-1,128,000,000 | $-1,308,000,000 |
| Financing Cash Flow | $-3,256,000,000 | $-3,389,000,000 | $-2,793,000,000 | $-952,000,000 |
| Cash Flow From Continuing Financing Activities | $-3,256,000,000 | $-3,389,000,000 | $-2,793,000,000 | $-952,000,000 |
| Net Other Financing Charges | $132,000,000 | $-91,000,000 | $18,000,000 | $-18,000,000 |
| Cash Dividends Paid | $-1,823,000,000 | $-1,789,000,000 | $-1,749,000,000 | $-1,691,000,000 |
| Common Stock Dividend Paid | $-1,823,000,000 | $-1,789,000,000 | $-1,749,000,000 | $-1,691,000,000 |
| Net Common Stock Issuance | $-1,210,000,000 | $-1,739,000,000 | $-1,128,000,000 | $-1,308,000,000 |
| Other | ||||
| Repayment Of Debt | $-655,000,000 | $-503,000,000 | $-903,000,000 | $-406,000,000 |
| Issuance Of Debt | $1,188,000,000 | $2,000,000 | $1,495,000,000 | $1,513,000,000 |
| Interest Paid Supplemental Data | $270,000,000 | $302,000,000 | $280,000,000 | $151,000,000 |
| Income Tax Paid Supplemental Data | $913,000,000 | $933,000,000 | $937,000,000 | $945,000,000 |
| End Cash Position | $1,288,000,000 | $1,096,000,000 | $966,000,000 | $775,000,000 |
| Beginning Cash Position | $1,096,000,000 | $966,000,000 | $775,000,000 | $832,000,000 |
| Effect Of Exchange Rate Changes | $67,000,000 | $-54,000,000 | $-19,000,000 | $-60,000,000 |
| Changes In Cash | $125,000,000 | $184,000,000 | $210,000,000 | $3,000,000 |
| Proceeds From Stock Option Exercised | $101,000,000 | $638,000,000 | $380,000,000 | $418,000,000 |
| Common Stock Payments | $-1,210,000,000 | $-1,739,000,000 | $-1,128,000,000 | $-1,308,000,000 |
| Net Issuance Payments Of Debt | $-456,000,000 | $-408,000,000 | $-314,000,000 | $1,647,000,000 |
| Net Short Term Debt Issuance | $-989,000,000 | $93,000,000 | $-906,000,000 | $540,000,000 |
| Net Long Term Debt Issuance | $533,000,000 | $-501,000,000 | $592,000,000 | $1,107,000,000 |
| Long Term Debt Payments | $-655,000,000 | $-503,000,000 | $-903,000,000 | $-406,000,000 |
| Long Term Debt Issuance | $1,188,000,000 | $2,000,000 | $1,495,000,000 | $1,513,000,000 |
| Net Investment Purchase And Sale | $54,000,000 | $-10,000,000 | $-4,000,000 | $-148,000,000 |
| Sale Of Investment | $752,000,000 | $564,000,000 | $502,000,000 | $322,000,000 |
| Purchase Of Investment | $-698,000,000 | $-574,000,000 | $-506,000,000 | $-470,000,000 |
| Net Business Purchase And Sale | $-293,000,000 | $0 | $0 | $-809,000,000 |
| Purchase Of Business | $-293,000,000 | $0 | $0 | $-809,000,000 |
| Change In Working Capital | $284,000,000 | $344,000,000 | $455,000,000 | $-726,000,000 |
| Change In Other Current Liabilities | $-95,000,000 | $-44,000,000 | $-64,000,000 | - |
| Change In Other Current Assets | $35,000,000 | $28,000,000 | $53,000,000 | - |
| Change In Payables And Accrued Expense | $251,000,000 | $516,000,000 | $309,000,000 | $-115,000,000 |
| Change In Inventory | $109,000,000 | $-100,000,000 | $194,000,000 | $-333,000,000 |
| Change In Receivables | $-16,000,000 | $-56,000,000 | $-37,000,000 | $-227,000,000 |
| Other Non Cash Items | $58,000,000 | $51,000,000 | $244,000,000 | $49,000,000 |
| Stock Based Compensation | $155,000,000 | $135,000,000 | $122,000,000 | $125,000,000 |
| Asset Impairment Charge | $919,000,000 | $0 | $0 | $721,000,000 |
| Deferred Tax | $-109,000,000 | $-77,000,000 | $-98,000,000 | $-78,000,000 |
| Deferred Income Tax | $-109,000,000 | $-77,000,000 | $-98,000,000 | $-78,000,000 |
| Depreciation Amortization Depletion | $630,000,000 | $605,000,000 | $567,000,000 | $545,000,000 |
| Depreciation And Amortization | $630,000,000 | $605,000,000 | $567,000,000 | $545,000,000 |
| Net Income From Continuing Operations | $2,261,000,000 | $3,049,000,000 | $2,455,000,000 | $1,967,000,000 |
| Net PPE Purchase And Sale | - | $0 | $0 | $47,000,000 |
| Sale Of PPE | - | $0 | $0 | $47,000,000 |
| Change In Other Working Capital | - | $-16,000,000 | $-11,000,000 | $-51,000,000 |
| Gain Loss On Sale Of PPE | - | $0 | $0 | $-47,000,000 |
| Pension And Employee Benefit Expense | - | - | - | - |
Fetched: 2026-05-25